Quoin Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Quoin Pharmaceuticals has a total shareholder equity of $5.4M and total debt of $3.1M, which brings its debt-to-equity ratio to 56.5%. Its total assets and total liabilities are $11.4M and $5.9M respectively.
Key information
56.5%
Debt to equity ratio
US$3.07m
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.31m |
| Equity | US$5.44m |
| Total liabilities | US$5.95m |
| Total assets | US$11.39m |
Financial Position Analysis
Short Term Liabilities: QNRX's short term assets ($10.5M) exceed its short term liabilities ($3.5M).
Long Term Liabilities: QNRX's short term assets ($10.5M) exceed its long term liabilities ($2.5M).
Debt to Equity History and Analysis
Debt Level: QNRX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if QNRX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QNRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: QNRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.1% each year